Novel ultra-high-frequency electrocardiogram tool for the description of the ventricular depolarization pattern before and during cardiac resynchronization.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
01 2020
Historique:
received: 11 10 2019
revised: 18 11 2019
accepted: 23 11 2019
pubmed: 4 12 2019
medline: 27 10 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

The present study introduces a new ultra-high-frequency 14-lead electrocardiogram technique (UHF-ECG) for mapping ventricular depolarization patterns and calculation of novel dyssynchrony parameters that may improve the selection of patients and application of cardiac resynchronization therapy (CRT). Components of the ECG in sixteen frequency bands within the 150 to 1000 Hz range were used to create ventricular depolarization maps. The maximum time difference between the UHF QRS complex centers of mass of leads V1 to V8 was defined as ventricular electrical dyssynchrony (e-DYS), and the duration at 50% of peak voltage amplitude in each lead was defined as the duration of local depolarization (Vd). Proof of principle measurements was performed in seven patients with left (left bundle branch block) and four patients with right bundle branch block (right bundle branch block) before and during CRT using biventricular and His-bundle pacing. The acquired activation maps reflect the activation sequence under the tested conditions. e-DYS decreased considerably more than QRS duration, during both biventricular pacing (-50% vs -8%) and His-bundle pacing (-77% vs -13%). While biventricular pacing slightly increased Vd, His-bundle pacing reduced Vd significantly (+11% vs -36%), indicating the contribution of the fast conduction system. Optimization of biventricular pacing by adjusting VV-interval showed a decrease of e-DYS from 102 to 36 ms with only a small Vd increase and QRS duration decrease. The UHF-ECG technique provides novel information about electrical activation of the ventricles from a standard ECG electrode setup, potentially improving the selection of patients for CRT and application of CRT.

Identifiants

pubmed: 31788894
doi: 10.1111/jce.14299
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-307

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Asirvatham SJ. Cardiac resynchronization: is electrical synchrony relevant? J Cardiovasc Electrophysiol. 2007;18(10):1028-1031 https://doi.org/10.1111/j.1540-8167.2007.00932.x
Van Deursen CJM, Blaauw Y, Witjens MI, et al. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice. J Electrocardiol. 2014;47(2):202-211. https://doi.org/10.1016/j.jelectrocard.2014.01.007
Langner PH, Geselowitz DB, Mansure FT, Lauer JA. High-frequency components in the electrocardiograms of normal subjects and of patients with coronary heart disease. Am Heart J. 1961;62:746-755.
Goldberger AL, Bhargava V, Froelicher V, et al. Effect of myocardial infarction on high-frequency QRS potentials. Circulation. 1981;64(1):34-42.
Nichols TL, Mirvis DM. Frequency content of the electrocardiogram. Spatial features and effects of myocardial infarction. J Electrocardiol. 1985;18(2):185-194.
Moss AJ, Hall WJ, Cannom DS, et al. MADIT-CRT trial investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338. https://doi.org/10.1056/NEJMoa0906431
Plesinger F, Jurak P, Halamek J, et al. Ventricular electrical delay measured from body surface ECGs is associated with cardiac resynchronization therapy response in left bundle branch block patients from the MADIT-CRT trial (multicenter automatic defibrillator implantation-cardiac resynchronization therapy response in left bundle branch block patients from the MADIT-CRT trial (multicenter automatic defibrillator implantation-cardiac resynchronization therapy). Circ Arrhythmia Electrophysiol. 2018;11(5):e005719. https://doi.org/10.1161/circep.117.005719
Halamek J, Leinveber P, Viscor I, et al. The relationship between ECG predictors of cardiac resynchronization therapy benefit. PLoS One. 2019;14(5):1-10. https://doi.org/10.1371/journal.pone.0217097
Jurak P, Halamek J, Meluzin J, et al. Ventricular dyssynchrony assessment using ultra-high frequency ECG technique. J Interv Card Electrophysiol. 2017;49(3):245-254. https://doi.org/10.1007/s10840-017-0268-0
Andrla P, Plesinger F, Halamek J, Leinveber P, Viscor I, Jurak P. A method for removing pacing artifacts from ultra-high-frequency electrocardiograms. 2018 Comput Cardiol Conf. 2018;45:1-5. https://doi.org/10.22489/cinc.2018.106
Plesinger F, Jurco J, Jurak P. Robust multichannel QRS detection. Comput Cardiol. 2014;2014:557-560.
Arnold AD, Shun-Shin MJ, Keene D, et al. His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2018;72(24):3112-3122. https://doi.org/10.1016/j.jacc.2018.09.073
Sharma PS, Dandamudi G, Herweg B, et al. Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience. Heart Rhythm. 2018;15(3):413-420. https://doi.org/10.1016/j.hrthm.2017.10.014
Upadhyay GA, Vijayaraman P, Nayak HM, et al. On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: a secondary analysis of His-SYNC. Heart Rhythm. 2019;16:1797-1807. https://doi.org/10.1016/j.hrthm.2019.05.009
Vijayaraman P, Huang W. Atrioventricular block at the distal His bundle: electrophysiological insights from left bundle branch pacing. Heart Rhythm Case Reports. 2019;5:233-236J. https://doi.org/10.1016/j.hrcr.2019.01.006
Auricchio A, Lumens J, Prinzen FW. Cardiac resynchronization therapy has a role in patients with right bundle branch block. Circ Arrhythmia Electrophysiol. 2014;7(3):532-541. https://doi.org/10.1161/CIRCEP.113.000628
Ploux S, Lumens J, Whinnett Z, et al. Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61(24):2435-43.
Jia P, Ramanathan C, Ghanem RN, Ryu K, Varma N, Rudy Y. Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses. Heart Rhythm. 2006;3(3):296-310. https://doi.org/10.1016/j.hrthm.2005.11.025
Huntjens P, Ploux S, Strik M, et al. Electrical substrates driving response to cardiac resynchronization therapy: a combined clinical-computational evaluation. Circ Arrhythm Electrophysiol. 2018;11(4):1-12. https://doi.org/10.1161/CIRCEP.118.006613

Auteurs

Pavel Jurak (P)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Karol Curila (K)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Pavel Leinveber (P)

International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
First Department of Internal Medicine-Cardioangiology, Faculty of Medicine of Masaryk University, St Anne's University Hospital, Brno, Czech Republic.

Frits W Prinzen (FW)

Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Ivo Viscor (I)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Filip Plesinger (F)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Radovan Smisek (R)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.
Department of Biomedical Engineering, The Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czech Republic.

Radka Prochazkova (R)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Pavel Osmancik (P)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Josef Halamek (J)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Magdalena Matejkova (M)

International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.

Jolana Lipoldova (J)

International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
First Department of Internal Medicine-Cardioangiology, Faculty of Medicine of Masaryk University, St Anne's University Hospital, Brno, Czech Republic.

Miroslav Novak (M)

International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
First Department of Internal Medicine-Cardioangiology, Faculty of Medicine of Masaryk University, St Anne's University Hospital, Brno, Czech Republic.

Roman Panovsky (R)

International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
First Department of Internal Medicine-Cardioangiology, Faculty of Medicine of Masaryk University, St Anne's University Hospital, Brno, Czech Republic.

Petr Andrla (P)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Vlastimil Vondra (V)

Institute of Scientific Instruments, The Czech Academy of Sciences, Brno, Czech Republic.

Petr Stros (P)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Jana Vesela (J)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Dalibor Herman (D)

Department of Cardiology, Cardiocenter, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH